Chemoreduction for retinoblastoma: Analysis of tumor control and risks for recurrence in 457 tumors

Transactions of the American Ophthalmological Society

Volumn 102, Issue , 2004, Pages 35-45

  Shields, Carol L ^a   Mashayekhi, Arman ^a   Cater, Jacqueline ^a   Shelil, Abdallah ^a   Meadows, Anna T ^b   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; BEAM THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CONTROLLED STUDY; CRYOTHERAPY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEWBORN; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINA MACULA LUTEA; RETINOBLASTOMA; TUMOR LOCALIZATION; TUMOR RECURRENCE; ADOLESCENT; ADULT; CHILD; ENUCLEATION; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; RETINA TUMOR; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRYOTHERAPY; ETOPOSIDE; EYE ENUCLEATION; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFANT; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RETINAL NEOPLASMS; RETINOBLASTOMA; RISK ASSESSMENT; RISK FACTORS; VINCRISTINE;

EID: 17244367859     PISSN: 15456110     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Shields CL, Shields JA. Chemotherapy for retinoblastoma [editorial]. Med Pediatr Oncol 2002;38:377-378.
2. Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus 1999;36:8-18.
3. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-664.
4. Wilson MW, Galindo CR, Haik BG, et al. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Ophthalmology 2001;108:2106-2115.
5. Gombos DS, Kelly A, Coen PG, et al. Retinoblastoma treated with primary chemotherapy alone: the significance of tumor size, location and age. Br J Ophthalmol 2002;86:80-83.
6. Kingston JE, Hungerford JL, Madreperla SA, et al. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 1996;114:1339-1347.
7. Murphree AL, Villablanca JG, Deegan WF, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1348-1356.
8. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 1996;114:1321-1328.
9. Shields CL, DePotter P, Himmelstein B, et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1330-1338.
10. Shields CL, Honavar SG, Shields JA, et al. Factors predictive of recurrence of retinal tumor, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002;120:460-464.
11. Shields JA, Shields CL. Management and prognosis of retinoblastoma. In: Intraocular Tumors. A Text and Atlas. Philadelphia: WB Saunders; 1992:377-391.
12. Shields CL, Santos C, Diniz W, et al. Thermotherapy for retinoblastoma. Arch Ophthalmol 1999;117:885-893.
13. Shields CL, Mashayekhi A, Shelil A, et al. Macular retinoblastoma managed with chemoreduction. Analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Poster presented at: International Congress of Ocular Oncology; January 23-27, 2004; Hyderabad, India.
14. Shields JA, Parsons H, Shields CL, et al. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol 1989;108:260-264.
15. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol 1963;67:164-172.
16. Shields JA, Shields CL. Retinoblastoma. In: Atlas of Intraocular Tumors. Philadelphia: Lippincott Williams & Wilkins; 1999:207-232.
17. Epstein J, Shields CL, Shields JA. Trends in the management of retinoblastoma. Evaluation of 1196 consecutive eyes during 1974-2001. J Pediatr Ophthalmol Strabismus 2003;40:196-203.
18. Shields CL, Shields JA, Needle M, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 1997;104:2101-2111.
19. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12-17.
20. Levy C, Doz F, Quintana E, et al. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results. Br J Ophthalmol 1998;82:1154-1158.
21. Singh AD, Shields CL, Shields JA. Lack of response to chemoreduction in presumed well differentiated retinoblastoma. J Pediatr Ophthalmol Strabismus 2002;39:107-109.
22. Shields CL. In discussion of: Lee TC, Hayashi NI, Dunkel IJ, et al. New retinoblastoma tumor formation in children initially treated with systemic carboplatin. Ophthalmology 2003;110:1994-1995.
23. Lumbroso L, Doz F, Urbieta M, et al. Chemothermotherapy in the management of retinoblastoma. Ophthalmology 2002;109:1130-1136.
24. Lee TC, Hayashi NI, Dunkel IJ, et al. New retinoblastoma tumor formation in children initially treated with systemic carboplatin. Ophthalmology 2003;110:1989-1994.
25. Shields CL, Shelil A, Cater J, et al. Development of new retinoblastomas following six cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Arch Ophthalmol 2003;121:1571-1576.